Study: NCT02214433

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo IV Solution
Description: A sterile IV solution of 5% dextrose in water

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Debio 1450 IV Solution
Description: A white to off-white powder (40 mg Debio 1450 per vial) to be reconstituted and formulated in a sterile IV solution of 5% dextrose in water

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Debio 1450 IV Solution
Description: A white to off-white powder (40 mg Debio 1450 per vial) to be reconstituted and formulated in a sterile IV solution of 5% dextrose in water

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Debio 1450 IV Solution
Description: A white to off-white powder (40 mg Debio 1450 per vial) to be reconstituted and formulated in a sterile IV solution of 5% dextrose in water

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Debio 1450 IV Solution
Description: A white to off-white powder (40 mg Debio 1450 per vial) to be reconstituted and formulated in a sterile IV solution of 5% dextrose in water

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Debio 1450 IV Solution
Description: A white to off-white powder (40 mg Debio 1450 per vial) to be reconstituted and formulated in a sterile IV solution of 5% dextrose in water

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Debio 1450 IV Solution
Description: A white to off-white powder (40 mg Debio 1450 per vial) to be reconstituted and formulated in a sterile IV solution of 5% dextrose in water

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Debio 1450 IV Solution
Description: A white to off-white powder (40 mg Debio 1450 per vial) to be reconstituted and formulated in a sterile IV solution of 5% dextrose in water

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Tablet or Capsule
Description: Placebo tablet or capsule, matching Debio 1450 coated tablet or capsule

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Debio 1450 Tablet
Description: Debio 1450 40 mg coated tablets

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Debio 1450 Tablet
Description: Debio 1450 40 mg coated tablets

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Debio 1450 Tablet
Description: Debio 1450 40 mg coated tablets

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Debio 1450 Tablet
Description: Debio 1450 40 mg coated tablets

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Debio 1450 Capsule
Description: Debio 1450 40 mg capsules

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Debio 1450 Capsule
Description: Debio 1450 40 mg capsules

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Debio 1450 Capsule
Description: Debio 1450 40 mg capsules

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Debio 1450 Capsule
Description: Debio 1450 40 mg capsules

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Debio 1450 Oral Solution
Description: Lyophilized Debio 1450 (40 mg per vial) reconstituted in 5% dextrose in water

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pantoprazole
Description: Pantoprazole 40 mg orally

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pantoprazole
Description: Pantoprazole 40 mg orally